The explosive growth of genomic and proteomic data has ushered in a new era of molecular medicine in which cancer detection, diagnosis and treatment are tailored to each individual's molecular profile.
Developed by May Dongmei Wang and her team in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, the programs -- caCORRECT and omniBioMarker -- remove noise and artifacts, and identify and validate biomarkers from microarray data. Funding to develop the programs was provided by the National Institutes of Health, the Georgia Cancer Coalition, Microsoft Research and Hewlett-Packard.
caCORRECT -- chip artifact CORRECTion -- is a software program that improves the quality of collected microarray data, ultimately leading to improved biomarker selection. Widely used Affymetrix microarrays contain thousands of probes, each including a 25-oligo sequence, which are used to detect mRNA expression levels.
"Once someone has collected microarray data, it is important to run quality control on it and remove any problematic points of data that could highlight incorrect biomarkers when analyzed," explained Wang, who is also director of the biocomputing and bioinformatics core in the Emory-Georgia Tech National Cancer Institute Center for Cancer Nanotechnology Excellence (CCNE).
Since each microarray chip contains thousands of spots, it is easy for a few spots to become marred by artifacts and noise. These unusable portions are typically the result of experimental variations by different laboratory technicians or errors that create scratches, edge effects and bubble effects on the data.
caCORRECT removes the noise and artifacts from the data, while retaining high-quality genes on the array. The software can also effectively recover lost information that has been obscured by artifacts.
In collaboration with Andrew N. Young, an associate professor in pathology and laboratory medicine at Emory University School of Medicine and clinical laboratory director at Grady Health System, Wang and graduate students Todd Stokes, Martin Ahrens and Richard Moffitt validated the caCORRECT software. A large-scale survey of public data and data from Young's laboratory demonstrated the ability of caCORRECT to assess and improve the quality of a wide array of datasets.
"caCORRECT is a quality assurance tool that allows researchers to utilize and trust imperfect experimental microarray data that they spent a tremendous amount of time and money to generate," added Wang. "caCORRECT improves the downstream analysis of microarray data and should be used before conducting biomarker selection, therapeutic target studies, or pathway analysis studies in bioinformatics and systems biology."
Once the quality of the data is assured with caCORRECT, researchers can use the caBIG-certified omniBioMarker software to identify and validate biomarkers from the high-throughput gene expression data.
Candidate cancer biomarkers are typically genes expressed at different levels in cancer patients compared to healthy subjects. omniBioMarker searches these groups of patient data for genes with the highest potential for accurately determining whether a patient has cancer. However, because individual genes are not expressed independently, the software also identifies groups of genes that act in concert.
The advantage of the omniBioMarker software is that it fine-tunes biomarker selection to a particular dataset or clinical problem based on prior biological knowledge. It also applies unique analysis parameters for each specific clinical problem. The parameters are optimal when the software selects genes that are known to be relevant biomarkers based on clinical observations and laboratory experiments available in literature and public databases. Then the software finds new potential biomarkers for experimental validation.
Wang, graduate student John Phan and Young tested the ability of the software to identify biomarkers in clinical renal cancer microarray data. The researchers selected renal cancer for study because it has several distinct subtypes, which can appear in the same person in varying degrees and must be treated according to the diagnosed subtype to maximize treatment success. The results indicate that integrating prior laboratory and clinical knowledge with the microarray data improves biomarker selection.
"Using omniBioMarker to create an optimal metric for ranking and identifying novel biomarkers reduces the number of false discoveries, increases the number of true discoveries, reduces the required time for validation and increases the overall efficiency of the process," noted Wang.
Since receiving caBIG silver-level compatibility certification for caCORRECT and omniBioMarker, Wang and her team have been working on getting two more software programs certified -- Q-IHC, a tool that analyzes and quantifies multi-spectral images such as quantum dot-stained histopathological images, and omniVisGrid, a grid-based tool that visualizes data and analysis processes of microarrays, biological pathways and clinical outcomes.
This work was funded by grant numbers R01CA108468, P20GM072069 and U54CA119338 from the National Institutes of Health (NIH). The content is solely the responsibility of the principal investigator and does not necessarily represent the official view of the NIH.
Abby Vogel | EurekAlert!
Researchers achieve HD video streaming at 10,000 times lower power
20.04.2018 | University of Washington
An AI that makes road maps from aerial images
18.04.2018 | Massachusetts Institute of Technology, CSAIL
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy